News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canada's EndoCeutics Files for $75 Million US IPO


2/28/2007 9:27:05 AM

WASHINGTON, Feb 27 (Reuters) - Canada's EndoCeutics Inc., a pharmaceutical firm developing hormone therapies for breast cancer and other endocrine-related disorders, said on Tuesday itQ is planning an initial public offering.

>>> Discuss This Story


Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES